【Ingredients】 This product is a compound preparation, and its components are: each tablet contains 0.125g of sulbactam pivoxil and 0.125g of amoxicillin.

【Properties】This product is an orange-yellow tablet.

【Indications】

This product is suitable for the following mild and moderate infectious diseases caused by β-lactamase-producing pathogens that are resistant to amoxicillin but sensitive to this product, including:

1. Upper respiratory tract infections: such as ear, nose and throat infections, namely otitis media, sinusitis, tonsillitis and pharyngitis;

2. Lower respiratory tract infection: such as pneumonia, acute bronchitis and acute exacerbation of chronic bronchitis, bronchiectasis, etc.;

3. Urogenital infection: such as cystitis and urethritis, pyelonephritis, gynecological infection, postpartum infection, etc.;

4. Skin and soft tissue infections: such as cellulitis, wound infection, furuncle, pyodermatitis and impetigo, venereal diseases, gonorrhea, etc.;

5. Oral infection: such as oral abscess, surgical medication, etc.;

6. Other infections: such as bacterial endocarditis, peritonitis, osteomyelitis, typhoid and paratyphoid, prevention of endocarditis, etc.

【Specification】0.25g (C₁₆H₁₉N₃O₅S 0.125g and C₈H₁₁NO₅S 0.125g)

【Dosage】

Usage: Oral.

Dosage: Adults and children over 12 years old: 2 to 4 tablets each time, once every 8 hours;

Children 6 to 12 years old: 2 tablets each time, taken once every 8 hours;

Children 2 to 6 years old: 1 tablet each time, taken once every 8 hours;

Children 9 months to 2 years old: 1/2 tablet each time, take once every 8 hours.

Moderate renal insufficiency (creatinine clearance 10-30ml/min): take 2-4 tablets every 12 hours;

Severe renal insufficiency (creatinine clearance <10ml/min): take less than 2 tablets every 12 hours.

【Storage】 Sealed and stored in a cool, dark and dry place.

【Package】Aluminum-plastic blister packaging, 6 pieces/box, 12 pieces/box, 18 pieces/box.

【Validity period】24 months.

【Executive Standard】 The Third Supplement to the 2010 Edition of the Chinese Pharmacopoeia

【Approval No.】Guoyao Zhunzi H20061148